Improved COVID-19 outcomes in CAR-T patients in the age of vaccination and preemptive pharmacotherapeutics

Leuk Lymphoma. 2023 Dec;64(12):2037-2041. doi: 10.1080/10428194.2023.2248329. Epub 2023 Aug 21.
No abstract available

MeSH terms

  • COVID-19* / prevention & control
  • Humans
  • Immunotherapy, Adoptive
  • Receptors, Chimeric Antigen*
  • Vaccination

Substances

  • Receptors, Chimeric Antigen